What problem does BlueOcean Swiss solve? (or: what human need does it satisfy?) and how exactly does it do so?
First Tokenized Medtech VC Fund
BlueOcean Ventures is a Swiss venture capital firm specialized in investing in ventures from the medical field. For the first time, the BlueOcean STO gives investors the possibility of buying a tradable token (BOV Token) in the highly illiquid asset class of Swiss and European Medtech and life science venture capital investments. 5 Existing portfolio companies, This STO will allow investing in more startups in order to reach a portfolio size of 8 to 12.
How is the idea monetized? How do the token holders profit?
Token holders will be able to trade with their tokens and invest in other startups
Other Important Info
BOV token is a security token
BlueOceanSwiss's team members.
Emmanuel de Watteville
General Partner and Co-Founder
Head of Operations
Launch of BlueOcean Ventures I
Launch of the second fund, BlueOcean Ventures II
BlueOcean Ventures II invests in Ava AG, Rheon Medical SA, and Abionic SA
BlueOcean Ventures II achieves an impressive 48% growth of its portfolio value until end 2017 (audited numbers)
Set up of Special STO Investment Vehicle in Singapore
BlueOcean Ventures II invest in Volumina Medical SA and Luciole Medical AG, Start of the presale of the STO
End of the STO. 100% of the STO net proceeds are invested into BlueOcean Ventures II
BEGINNING OF 2019
BOV token trades on various exchanges and BlueOcean Ventures II has a portfolio of 6 startups
BlueOcean Ventures II has a portfolio of 8 to 12 companies. Initial expected proceed to token holders from first sale of a portfolio company
1 USD = 1 BOV
3 200 000 USD
36 000 000 USD
ETH, BTC, USD
China, Iran, North Korea
Questions & Answers
Loading questions and answers...